// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Another public health crisis looms in the wake of the COVID-19 pandemic.
The scale and speed of the global vaccine research and development effort in response to COVID-19
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis